Need Assistance?
  • US & Canada:
    +
  • UK: +

GLK-19

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

GLK-19 is a synthetic construct and has antibacterial activity.

Category
Functional Peptides
Catalog number
BAT-012049
CAS number
1225014-04-9
Molecular Formula
C102H194N26O20
Molecular Weight
2104.79
IUPAC Name
(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-4-methylpentanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]hexanoic acid
Sequence
GLKKLLGKLLKKLGKLLLK
InChI
InChI=1S/C102H194N26O20/c1-59(2)47-75(87(132)111-57-85(130)113-69(34-20-27-41-104)90(135)124-82(54-66(15)16)100(145)128-83(55-67(17)18)101(146)127-79(51-63(9)10)97(142)120-74(102(147)148)39-25-32-46-109)121-93(138)72(37-23-30-44-107)116-92(137)71(36-22-29-43-106)119-96(141)78(50-62(7)8)126-99(144)81(53-65(13)14)123-89(134)68(33-19-26-40-103)114-86(131)58-112-88(133)76(48-60(3)4)122-98(143)80(52-64(11)12)125-94(139)73(38-24-31-45-108)117-91(136)70(35-21-28-42-105)118-95(140)77(49-61(5)6)115-84(129)56-110/h59-83H,19-58,103-110H2,1-18H3,(H,111,132)(H,112,133)(H,113,130)(H,114,131)(H,115,129)(H,116,137)(H,117,136)(H,118,140)(H,119,141)(H,120,142)(H,121,138)(H,122,143)(H,123,134)(H,124,135)(H,125,139)(H,126,144)(H,127,146)(H,128,145)(H,147,148)/t68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-/m0/s1
InChI Key
GLVLTCSPTDZARJ-QVZMCLSFSA-N
Canonical SMILES
CC(C)CC(C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)O)NC(=O)CN
1. Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database
Guangshun Wang, Karen M Watson, Alan Peterkofsky, Robert W Buckheit Jr Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6. doi: 10.1128/AAC.01448-09. Epub 2010 Jan 19.
To identify novel anti-HIV-1 peptides based on the antimicrobial peptide database (APD; http://aps.unmc.edu/AP/main.php), we have screened 30 candidates and found 11 peptides with 50% effective concentrations (EC(50)) of 1, increases in the Arg contents of amphibian maximin H5 and dermaseptin S9 peptides and the database-derived GLK-19 peptide improved the TIs. These examples demonstrate that the APD is a rich resource and a useful tool for developing novel HIV-1-inhibitory peptides.
2. APD2: the updated antimicrobial peptide database and its application in peptide design
Guangshun Wang, Xia Li, Zhe Wang Nucleic Acids Res. 2009 Jan;37(Database issue):D933-7. doi: 10.1093/nar/gkn823. Epub 2008 Oct 28.
The antimicrobial peptide database (APD, http://aps.unmc.edu/AP/main.php) has been updated and expanded. It now hosts 1228 entries with 65 anticancer, 76 antiviral (53 anti-HIV), 327 antifungal and 944 antibacterial peptides. The second version of our database (APD2) allows users to search peptide families (e.g. bacteriocins, cyclotides, or defensins), peptide sources (e.g. fish, frogs or chicken), post-translationally modified peptides (e.g. amidation, oxidation, lipidation, glycosylation or d-amino acids), and peptide binding targets (e.g. membranes, proteins, DNA/RNA, LPS or sugars). Statistical analyses reveal that the frequently used amino acid residues (>10%) are Ala and Gly in bacterial peptides, Cys and Gly in plant peptides, Ala, Gly and Lys in insect peptides, and Leu, Ala, Gly and Lys in amphibian peptides. Using frequently occurring residues, we demonstrate database-aided peptide design in different ways. Among the three peptides designed, GLK-19 showed a higher activity against Escherichia coli than human LL-37.
3. Genetic diversity of chickpea (Cicer arietinum L.) germplasm in Pakistan as revealed by RAPD analysis
F Ahmad, A I Khan, F S Awan, B Sadia, H A Sadaqat, S Bahadur Genet Mol Res. 2010;9(3):1414-20. doi: 10.4238/vol9-3gmr862.
Genetic diversity analysis of chickpea germplasm can provide practical information for the selection of parental material and thus assist in planning breeding strategies. Chickpea seed is a good source of carbohydrates and proteins, constituting 80% of the total dry seed weight. Released cultivars and advanced lines of 30 chickpea genotypes were subjected to RAPD analysis for assessment of genetic diversity. We used 16 RAPD primers. Amplification of genomic DNA of the 30 genotypes yielded 62 fragments that could be scored. The number of amplification products produced per primer varied from two to four, with a mean of three bands. The total number of bands amplified by 16 anchored primers varied from 16 to 34. The primer GLK-15 produced the largest number (N = 4) of fragments, whereas primers GLK-19 and GLD-19 produced the smallest number (N = 1) of fragments. The single band produced by the GTGTGCCCCA primer in the PB-2000 and 07005 genotypes may be attributed to temperature tolerance phenotypes.
Online Inquiry
Verification code
Inquiry Basket